Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Franck J. D. Mennechet, Océane Paris, Aline Raissa Ouoba, Sofia Salazar Arenas, Sodiomon B. Sirima, Guy R. Takoudjou Dzomo, Amidou Diarra, Isidore T Traore, Dramane Kania, Karsten Eichholz, Eric A. Weaver, Edouard Tuaillon & Eric J. Kremer. (2019) A review of 65 years of human adenovirus seroprevalence. Expert Review of Vaccines 18:6, pages 597-613.
Read now
Read now
Xi Yang, Xiang Wang, Yufeng Song, Ping Zhou, Dapeng Li, Chao Zhang, Xia Jin, Zhong Huang & Dongming Zhou. (2019) Chimpanzee adenoviral vector prime-boost regimen elicits potent immune responses against Ebola virus in mice and rhesus macaques. Emerging Microbes & Infections 8:1, pages 1086-1097.
Read now
Read now
Jingao Guo, Moumita Mondal & Dongming Zhou. (2018) Development of novel vaccine vectors: Chimpanzee adenoviral vectors. Human Vaccines & Immunotherapeutics 14:7, pages 1679-1685.
Read now
Read now
Xuehua Zheng, Xia Rong, Ying Feng, Xikui Sun, Liang Li, Qian Wang, Min Wang, Wenkuan Liu, Chufang Li, Yiyu Yang, Rong Zhou, Jiahai Lu, Liqiang Feng & Ling Chen. (2017) Seroprevalence of neutralizing antibodies against adenovirus type 14 and 55 in healthy adults in Southern China. Emerging Microbes & Infections 6:1, pages 1-8.
Read now
Read now
Zichun Xiang, Linlin Li, Lili Ren, Li Guo, Zhengde Xie, Chunyan Liu, Taisheng Li, Ming Luo, Gláucia Paranhos-Baccalà, Wenbo Xu & Jianwei Wang. (2017) Seroepidemiology of enterovirus D68 infection in China. Emerging Microbes & Infections 6:1, pages 1-5.
Read now
Read now
Chao Zhang & Dongming Zhou. (2016) Adenoviral vector-based strategies against infectious disease and cancer. Human Vaccines & Immunotherapeutics 12:8, pages 2064-2074.
Read now
Read now
Franck JD Mennechet, Thi Thu Phuong Tran, Karsten Eichholz, Philippe van de Perre & Eric J Kremer. (2015) Ebola virus vaccine: benefit and risks of adenovirus-based vectors. Expert Review of Vaccines 14:11, pages 1471-1478.
Read now
Read now
Articles from other publishers (25)
Peng ZouQi WangPanli ZhangShengxue LuoCong WangEnhui ZhangLing ZhangChengyao LiTingting Li. (2023) Characterization of Pre-Existing Neutralizing Antibody to Human Adenovirus Types 5 and 49 and Simian Type 23 in Chinese Population. Viral Immunology 36:9, pages 617-625.
Crossref
Crossref
Man Xing, Yihan Wang, Xinyu Wang, Jiaojiao Liu, Weiqian Dai, Gaowei Hu, Furong He, Qian Zhao, Ying Li, Lingjin Sun, Yuyan Wang, Shujuan Du, Zhongwei Dong, Chongjie Pang, Zhidong Hu, Xiaoyan Zhang, Jianqing Xu, Qiliang Cai & Dongming Zhou. (2023) Broad-spectrum vaccine via combined immunization routes triggers potent immunity to SARS-CoV-2 and its variants. Journal of Virology 97:10.
Crossref
Crossref
Shen Wang, Bo Liang, Weiqi Wang, Ling Li, Na Feng, Yongkun Zhao, Tiecheng Wang, Feihu Yan, Songtao Yang & Xianzhu Xia. (2023) Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases. Signal Transduction and Targeted Therapy 8:1.
Crossref
Crossref
Haisu Yi, Qian Wang, Jiankai Deng, Hengchun Li, Yingkun Zhang, Zhilong Chen, Tianxin Ji, Wenming Liu, Xuehua Zheng, Qinghua Ma, Xinxin Sun, Yudi Zhang, Xuegao Yu, Mengzhang He, Ling Chen & Ying Feng. (2022) Seroprevalence of neutralizing antibodies against adenovirus type 26 and 35 in healthy populations from Guangdong and Shandong provinces, China. Virologica Sinica 37:5, pages 716-723.
Crossref
Crossref
A. A. Soldatov, Zh. I. Avdeeva, D. V. Gorenkov, L. M. Khantimirova, S. G. Guseva & V. A. Merkulov. (2022) Challenges in development and authorisation of gene therapy products. Biological Products. Prevention, Diagnosis, Treatment 22:1, pages 6-22.
Crossref
Crossref
Nawamin Sa-nguanmoo, Katawut Namdee, Mattaka Khongkow, Uracha Ruktanonchai, YongXiang Zhao & Xing-Jie Liang. (2021) Review: Development of SARS-CoV-2 immuno-enhanced COVID-19 vaccines with nano-platform. Nano Research 15:3, pages 2196-2225.
Crossref
Crossref
Jiaojiao Liu, Kun Xu, Man Xing, Yue Zhuo, Jingao Guo, Meng Du, Qi Wang, Yaling An, Jinhe Li, Ping Gao, Yihan Wang, Furong He, Yingying Guo, Mingxi Li, Yuchao Zhang, Linqi Zhang, George F. Gao, Lianpan Dai & Dongming Zhou. (2021) Heterologous prime-boost immunizations with chimpanzee adenoviral vectors elicit potent and protective immunity against SARS-CoV-2 infection. Cell Discovery 7:1.
Crossref
Crossref
Peng Li, Yan Chen, An Tang, Fan Gao & Jian-Bo Yan. (2021) Seroprevalence of coxsackievirus A16 antibody among people of various age groups: a systematic review and meta-analysis. Archives of Public Health 79:1.
Crossref
Crossref
Marwa Alhashimi, Ahmed Elkashif, Ekramy E. Sayedahmed & Suresh K. Mittal. (2021) Nonhuman Adenoviral Vector-Based Platforms and Their Utility in Designing Next Generation of Vaccines for Infectious Diseases. Viruses 13:8, pages 1493.
Crossref
Crossref
Alexander Malogolovkin, Nizami Gasanov, Alexander Egorov, Marianna Weener, Roman Ivanov & Alexander Karabelsky. (2021) Combinatorial Approaches for Cancer Treatment Using Oncolytic Viruses: Projecting the Perspectives through Clinical Trials Outcomes. Viruses 13:7, pages 1271.
Crossref
Crossref
Mingxi Li, Jingao Guo, Shuaiyao Lu, Runhong Zhou, Hongyang Shi, Xuanling Shi, Lin Cheng, Qingtai Liang, Hongqi Liu, Pui Wang, Nan Wang, Yifeng Wang, Lili Fu, Man Xing, Ruoke Wang, Bin Ju, Li Liu, Siu-Ying Lau, Wenxu Jia, Xin Tong, Lin Yuan, Yong Guo, Hai Qi, Qi Zhang, Zhen Huang, Honglin Chen, Zheng Zhang, Zhiwei Chen, Xiaozhong Peng, Dongming Zhou & Linqi Zhang. (2021) Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection. Frontiers in Immunology 12.
Crossref
Crossref
Ian McDonald, Sam M. Murray, Catherine J. Reynolds, Daniel M. Altmann & Rosemary J. Boyton. (2021) Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2. npj Vaccines 6:1.
Crossref
Crossref
Qi WangYachun SunYuxia XuYilin WangHuafeng WangYongshui FuJean-Pierre AllainChengyao LiTingting Li. (2019) Seroprevalence of Human Adenovirus Type 5 Neutralizing Antibody in Common Marmosets Determined by a New Set of Two Assays. Viral Immunology 32:8, pages 348-354.
Crossref
Crossref
Xinci Xie, Chen Zhao, Qian He, Tianyi Qiu, Songhua Yuan, Longfei Ding, Lu Liu, Lang Jiang, Jing Wang, Linxia Zhang, Chao Zhang, Xiang Wang, Dongming Zhou, Xiaoyan Zhang & Jianqing Xu. (2019) Influenza Vaccine With Consensus Internal Antigens as Immunogens Provides Cross-Group Protection Against Influenza A Viruses. Frontiers in Microbiology 10.
Crossref
Crossref
Reena Goswami, Gayatri Subramanian, Liliya Silayeva, Isabelle Newkirk, Deborah Doctor, Karan Chawla, Saurabh Chattopadhyay, Dhyan Chandra, Nageswararao Chilukuri & Venkaiah Betapudi. (2019) Gene Therapy Leaves a Vicious Cycle. Frontiers in Oncology 9.
Crossref
Crossref
Xiaojuan Zhu, Tao Wu, Ying Chi, Yiyue Ge, Bin Wu, Minghao Zhou, Fengcai Zhu, Minjun Ji & Lunbiao Cui. (2018) Pyroptosis induced by enterovirus A71 infection in cultured human neuroblastoma cells. Virology 521, pages 69-76.
Crossref
Crossref
Kun Xu, Yufeng Song, Lianpan Dai, Yongli Zhang, Xuancheng Lu, Yijia Xie, Hangjie Zhang, Tao Cheng, Qihui Wang, Qingrui Huang, Yuhai Bi, William J. Liu, Wenjun Liu, Xiangdong Li, Chuan Qin, Yi Shi, Jinghua Yan, Dongming Zhou & George F. Gao. (2018) Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage. Journal of Virology 92:6.
Crossref
Crossref
Xiang Wang, Weihui Fu, Songhua Yuan, Xi Yang, Yufeng Song, Lulu Liu, Yudan Chi, Tao Cheng, Man Xing, Yan Zhang, Chao Zhang, Yong Yang, Caihong Zhu, Xiaoyan Zhang, Sidong Xiong, Jianqing Xu & Dongming Zhou. (2017) Both haemagglutinin-specific antibody and T cell responses induced by a chimpanzee adenoviral vaccine confer protection against influenza H7N9 viral challenge. Scientific Reports 7:1.
Crossref
Crossref
Chao Zhang, Yudan Chi & Dongming Zhou. 2017. Recombinant Virus Vaccines. Recombinant Virus Vaccines
3
13
.
Yilin Zhao, Jiansheng Liu, Haihao Zhang, Chen Guo, Longhui Xia, Fang Yang, Huai Yang, Qinxing Yang, Zhaoqing Yang & Shaohui Ma. (2016) Complete genome analysis of coxsackievirus A24 isolated in Yunnan, China, in 2013. Archives of Virology 161:6, pages 1705-1709.
Crossref
Crossref
Yong Li, Lianwen Wang, Liuyong Pang & Sanhong Liu. (2016) The data fitting and optimal control of a hand, foot and mouth disease (HFMD) model with stage structure. Applied Mathematics and Computation 276, pages 61-74.
Crossref
Crossref
Yong Yang, Yudan Chi, Xinying Tang, Hildegund C.J. Ertl & Dongming Zhou. (2016) Rapid, Efficient, and Modular Generation of Adenoviral Vectors via Isothermal Assembly. Current Protocols in Molecular Biology 113:1.
Crossref
Crossref
Shuai Wang, Chunwei Lan, Luwen Zhang, Haizhu Zhang, Zhijun Yao, Dong Wang, Jingbo Ma, Jiarong Deng & Shiguo Liu. (2015) Seroprevalence of Toxoplasma gondii infection among patients with hand, foot and mouth disease in Henan, China: a hospital-based study. Infectious Diseases of Poverty 4:1.
Crossref
Crossref
Juanjuan Gui, Zhifang Liu, Tianfang Zhang, Qihang Hua, Zhenggang Jiang, Bin Chen, Hua Gu, Huakun Lv & Changzheng Dong. (2015) Epidemiological Characteristics and Spatial-Temporal Clusters of Hand, Foot, and Mouth Disease in Zhejiang Province, China, 2008-2012. PLOS ONE 10:9, pages e0139109.
Crossref
Crossref
Chao Zhang, Yong Yang, Yudan Chi, Jieyun Yin, Lijun Yan, Zhiqiang Ku, Qingwei Liu, Zhong Huang & Dongming Zhou. (2015) Hexon-modified recombinant E1-deleted adenoviral vectors as bivalent vaccine carriers for Coxsackievirus A16 and Enterovirus 71. Vaccine 33:39, pages 5087-5094.
Crossref
Crossref